THERAtRAME Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $4.97M

  • Investors
  • 7

THERAtRAME General Information

Description

Developer of a drug discovery platform designed to discover TM-enzyme-type molecules against cancer. The company's platform develops new small molecule inhibitors targeting the tRNA epitranscriptomics and uncovers new druggable targets for diseases and new patients that could benefit from drug repositioning, enabling healthcare providers to offer new clinical drugs for cancer patients at an affordable price.

Contact Information

Website
www.theratrame.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenue de l'Hopital 1
  • 4000 Liege
  • Belgium
+32 04
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Avenue de l'Hopital 1
  • 4000 Liege
  • Belgium
+32 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

THERAtRAME Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 27-May-2026 $4.97M Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 01-Jan-2022 Completed Generating Revenue
To view THERAtRAME’s complete valuation and funding history, request access »

THERAtRAME Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view THERAtRAME’s complete cap table history, request access »

THERAtRAME Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

THERAtRAME Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gesval Lender/Debt Provider Minority
Kazoku Corporation Minority
Noshaq Venture Capital Minority
Qbic Fund Venture Capital Minority
Wallonie Entreprendre Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

THERAtRAME FAQs

  • When was THERAtRAME founded?

    THERAtRAME was founded in 2022.

  • Where is THERAtRAME headquartered?

    THERAtRAME is headquartered in Liege, Belgium.

  • What is the size of THERAtRAME?

    THERAtRAME has 18 total employees.

  • What industry is THERAtRAME in?

    THERAtRAME’s primary industry is Drug Discovery.

  • Is THERAtRAME a private or public company?

    THERAtRAME is a Private company.

  • What is the current valuation of THERAtRAME?

    The current valuation of THERAtRAME is .

  • What is THERAtRAME’s current revenue?

    The current revenue for THERAtRAME is .

  • How much funding has THERAtRAME raised over time?

    THERAtRAME has raised $4.97M.

  • Who are THERAtRAME’s investors?

    Gesval, Kazoku, Noshaq, Qbic Fund, and Wallonie Entreprendre are 5 of 7 investors who have invested in THERAtRAME.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process